DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Operating income
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual operating income history from SEC filings — each fiscal year as reported.
-$2.8MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net incomeDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating marginDMAAR Operating cash flowDMAAR Free cash flowDMAAR Capital expendituresDMAAR Return on equityDMAAR Stock buybacksDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →